SONOMIND™
Latest round
- Series A
Last raised
- May 2026
Total raised
- $26M
Investors
- 2
About SONOMIND™
Sonomind, founded in 2024, is a company located in Paris, France, that focuses on developing ultrasound therapies for mental health treatment. Sonomind specializes in innovative therapeutic solutions aimed at treating depression through a non-invasive approach utilizing ultrasound neuromodulation technology. Their core product leverages over 25 years of research conducted at the Physmed laboratory, focusing on deep transcranial ultrasound stimulation to target specific brain regions associated with depression. This technology is designed to provide rapid relief from severe treatment-resistant depression, achieving significant symptom reduction as evidenced by clinical studies. The company’s offerings are directed towards healthcare providers, including hospitals and mental health clinics, primarily in Europe and North America.Revenue generation for Sonomind is structured around the provision of its advanced ultrasound neuromodulation services to healthcare institutions. Transactions typically occur through partnerships with hospitals and mental health clinics, where the company offers treatment plans based on its proprietary technology. Specific pricing details for these services are set according to patient needs and treatment duration, reflecting the ongoing utility of their flagship offerings. By establishing a network of clinical partners, Sonomind is positioned to facilitate continuous revenue flow through the treatment of patients suffering from severe depression.
Who invested in SONOMIND™
2 investors across 2 rounds
See all investors in SONOMIND™
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SONOMIND™
Who invested in SONOMIND™?
SONOMIND™ has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SONOMIND™ raised?
SONOMIND™ has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SONOMIND™ last raise money?
SONOMIND™'s most recent round on record is a Series A, in May 2026.
What does SONOMIND™ do?
Sonomind, founded in 2024, is a company located in Paris, France, that focuses on developing ultrasound therapies for mental health treatment.
Where is SONOMIND™ headquartered?
SONOMIND™ is headquartered in Paris, France.
Which VCs invest in companies like SONOMIND™?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at SONOMIND™'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like SONOMIND™? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.